We have located links that may give you full text access.
English Abstract
Journal Article
[Beta-lactamases of clinical isolates of Enterobacteriaceae family].
Among 62 clinical strains of enterobacteria, isolated from intestinal tract, representatives of genus Escherichia made--67.4%, Klebsiella--4.84%, Citrobacter--4.84%, Enterobacter--8.06%, Proteus--6.45%, Morganella of 8.06%. Preparations of fluorquinolone group--gatifloxacin and moxifloxacin, the number of steady strains being from 0.0% to 33.3%, were the most effective in respect of enterobacteria The investigated strains of enterobacteria showed considerable resistance to beta-lactam antibiotics. The highest sensitivity has been noted to cefotaxim: Escherichia spp.--7.1%, Citrobacter spp.-0.0%, Klebsiella spp.--33.3%, Enterobacter spp.--20.0%, Proteus spp.--25.0%, Morganella spp.--20.0% of steady strains. Among 62 isolated strains of enterobacteria 48 produced beta-lactamases. Production of extended-spectrum beta-lactamases (ESBL) has been found out in 100% of strains of Klebsiella spp., 81.8% of Escherichia spp., 66.7% of Enterobacter spp., 33.3% of Citrobacter spp. and Proteus spp.--from total amount of strains producing beta-lactamases.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app